Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Enfuvirtide Fuzeon
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Abacavir Ziagen
Abacavir-Lamivudine Epzicom
Abacavir-Lamivudine-Zidovudine Trizivir
Didanosine Videx
Emtricitabine Emtriva
Lamivudine Epivir
Stavudine Zerit
Tenofovir alafenamide-Emtricitabine Descovy
Tenofovir DF Viread
Tenofovir DF-Emtricitabine Truvada and Multiple Generics
Zidovudine Retrovir
Zidovudine-Lamivudine Combivir
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Nevirapine Viramune
Rilpivirine Edurant
Atazanavir Reyataz
Atazanavir-Cobicistat Evotaz
Darunavir Prezista
Darunavir-Cobicistat Prezcobix
Fosamprenavir Lexiva
Indinavir Crixivan
Lopinavir-Ritonavir Kaletra
Nelfinavir Viracept
Saquinavir Invirase
Tipranavir Aptivus
Cobicistat Tybost
Ritonavir NorvirNational HIV Curriculum Podcast
Lead Editor
Editor
Editor
Keep Current on HIV Diagnosis, Management and Prevention
This podcast series explores practice-changing issues and updates in HIV diagnosis, management, and prevention through Case Discussions, Expert Interviews, and Literature Reviews.
November 19, 2024
Expert Interviews
Initial ART Regimens Considerations: A Discussion
23 min 43 sec
The three National HIV Curriculum Podcast editors share their perspectives on recent guideline changes to initial ART choices for treatment-naïve individuals with HIV, practical considerations for first line and alternate ART regimens, and the impact of M184V mutation.
October 18, 2024
Expert Interviews
Implementation of the New HHS Anal Cancer Screening Guidelines
40 min 44 sec
Dr. Jeff Schouten, UW faculty in Surgery and in Allergy and Infectious Diseases as well as ANCHOR trial co-investigator, discusses the new anal cancer screening guidelines for persons with HIV then focuses on implementation barriers and considerations for integrating the new recommendations into HIV primary care clinical practice.
September 27, 2024
Case Discussions
Pneumocystis Pneumonia: Management
17 min 16 sec
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss their approach to treating Pneumocystis Pneumonia (PCP or PJP) in a person with advanced HIV, including the use of antimicrobials, adjunctive steroids, and when to start ART.
September 12, 2024
Literature Reviews
The ANCHOR Study: Does Treatment of Anal HSIL Prevent Anal Cancer?
16 min 15 sec
This episode reviews a landmark study published in 2022 that aimed to answer the question of whether treating anal high-grade squamous intraepithelial lesions (HSIL) prevents anal cancer for persons with HIV, a question that was previously unanswered and that was key to informing the new anal cancer screening guidelines.
August 15, 2024
Case Discussions
Evaluation of Dyspnea in a Person with Advanced HIV
26 min 39 sec
Dyspnea in persons with advanced HIV has a broad differential diagnosis. National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss potential causes and diagnostic options with a specific focus on the wide array of diagnostics for Pneumocystis pneumonia (PCP), including blood tests, sputum stain types, DFA, and PCP PCR.
July 18, 2024
Expert Interviews
Semaglutide Studies in PWH & What to Consider Before Prescribing
31 min 2 sec
Dr. Kristine Erlandson, Associate Professor at the University of Colorado School of Medicine and SLIM LIVER study senior author, discusses recent key GLP-1 receptor agonist studies, clinical implications, and practical prescribing considerations for HIV primary care providers with National HIV Curriculum Podcast Lead Editor Dr. Brian Wood.
July 2, 2024
Literature Reviews
The SLIM LIVER Study: Use of Semaglutide for Persons with HIV
24 min 1 sec
This episode reviews literature about the recent SLIM LIVER study which evaluated the impact of semaglutide, a GLP-1 receptor agonist, on persons with HIV and discusses the important implications on clinical practice.
June 14, 2024
Case Discussions
CMV Retinitis: Evaluation and Management
24 min 14 sec
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss possible causes of visual changes in advanced HIV and the diagnosis and management of CMV retinitis in people with HIV.
May 23, 2024
Expert Interviews
Should People with HIV Take Aspirin for CVD Prevention?
14 min 49 sec
HIV exacerbates the risk for adverse cardiovascular events. Dr. Chris Longenecker, a University of Washington Associate Professor of Medicine, and National HIV Curriculum Podcast Lead Editor Dr. Brian Wood discuss the pros and cons around aspirin for primary prevention and how to counsel patients.
May 7, 2024
Case Discussions
Toxoplasma Encephalitis: Management
17 min 48 sec
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss the diagnosis and treatment of toxoplasma encephalitis, potential side effects, and when to start or restart HIV antiretroviral therapy.
April 15, 2024
Expert Interviews
Cardiovascular Side Effects of Antiretroviral Therapy
20 min 3 sec
Dr. Chris Longenecker, a University of Washington Associate Professor of Medicine, discusses the cardiovascular side effects, including effects on lipids, of common antiretroviral therapy (ART) drugs with National HIV Curriculum Podcast Lead Editor Dr. Brian Wood.
April 2, 2024
Case Discussions
Evaluation of Focal Neurological Symptoms in a Patient with Advanced HIV
13 min 17 sec
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss an approach to working up a patient with a CD4 <100 who presented with focal neurological deficits and abnormal brain imaging.
March 13, 2024
Expert Interviews
New Guidelines: Statin Therapy for People with HIV to Prevent CVD
22 min 54 sec
The first ever statin therapy guidelines to prevent cardiovascular disease (CVD) in people with HIV were released February 27, 2024. Dr. Chris Longenecker, a University of Washington Associate Professor of Medicine, and National HIV Curriculum Podcast Lead Editor Dr. Brian Wood discuss the recommendations and their clinical implications.
March 12, 2024
Expert Interviews
Pharmacologic Management of Hyperlipidemia
23 min 43 sec
Dr. Chris Longenecker, a University of Washington Associate Professor of Medicine, and National HIV Curriculum Podcast Lead Editor Dr. Brian Wood discuss treatment of hyperlipidemia for individuals with HIV (PWH), with a focus on tools to estimate cardiovascular disease risk, selecting lipid-lowering agents, and key drug-drug interactions, as well as managing adverse effects or nonresponse to initial therapy.
February 20, 2024
Case Discussions
Management of Cryptococcal Meningitis
22 min 15 sec
After diagnosing cryptococcal meningitis in the last episode, National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila review the complexities of managing a patient with HIV and cryptococcal meningitis.
February 6, 2024
Expert Interviews
REPRIEVE Statin Trial: Why is It Important?
22 min 21 sec
Dr. Chris Longenecker, a University of Washington Associate Professor of Medicine, discusses the REPRIEVE trial design and clinical practice implications with National HIV Curriculum Podcast Lead Editor Dr. Brian Wood.
January 23, 2024
Case Discussions
Evaluation of a Headache in Advanced HIV
21 min 59 sec
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss an approach to working up a headache in a patient with a CD4 count less than a 100.
January 9, 2024
Expert Interviews
Antiretroviral Therapy (ART) and Weight Gain
32 min 52 sec
Managing weight gain with the use of newer generation HIV ART regimens is controversial. Dr. Sara Bares, a University of Nebraska Associate Professor, discusses key studies and how to counsel patients about potential impacts of initiating or switching a regimen with National HIV Curriculum Podcast Lead Editor Dr. Brian Wood.